104.50
前日終値:
$104.50
開ける:
$103.86
24時間の取引高:
5.20M
Relative Volume:
0.63
時価総額:
$154.60B
収益:
$17.55B
当期純損益:
$2.03B
株価収益率:
76.28
EPS:
1.37
ネットキャッシュフロー:
$2.72B
1週間 パフォーマンス:
-1.45%
1か月 パフォーマンス:
+5.64%
6か月 パフォーマンス:
+16.11%
1年 パフォーマンス:
+40.49%
Boston Scientific Corp Stock (BSX) Company Profile
名前
Boston Scientific Corp
セクター
電話
508-683-4000
住所
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
BSX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
BSX
Boston Scientific Corp
|
104.50 | 156.88B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
ABT
Abbott Laboratories
|
131.30 | 234.53B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
SYK
Stryker Corp
|
376.62 | 150.65B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
80.68 | 110.81B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
74.99 | 45.75B | 5.54B | 4.18B | 623.10M | 7.00 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-04-16 | アップグレード | Needham | Hold → Buy |
2025-01-10 | アップグレード | Deutsche Bank | Hold → Buy |
2024-10-18 | ダウングレード | Needham | Buy → Hold |
2024-05-30 | 開始されました | Goldman | Buy |
2024-02-01 | アップグレード | Mizuho | Neutral → Buy |
2023-07-19 | 開始されました | Robert W. Baird | Outperform |
2023-06-30 | 開始されました | CL King | Buy |
2023-05-30 | 再開されました | Morgan Stanley | Overweight |
2023-03-29 | 開始されました | UBS | Buy |
2022-12-22 | 開始されました | Mizuho | Neutral |
2022-12-20 | 再開されました | Citigroup | Buy |
2022-10-18 | 開始されました | Barclays | Overweight |
2022-10-12 | 開始されました | Jefferies | Buy |
2022-07-06 | 開始されました | Wolfe Research | Outperform |
2022-05-27 | アップグレード | Needham | Hold → Buy |
2022-04-13 | 再開されました | Truist | Buy |
2022-03-02 | 再開されました | BofA Securities | Buy |
2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
2021-05-26 | ダウングレード | Needham | Buy → Hold |
2021-05-25 | 開始されました | Barclays | Overweight |
2021-04-15 | 開始されました | Atlantic Equities | Overweight |
2020-09-17 | 開始されました | Truist | Buy |
2020-09-11 | 開始されました | Wolfe Research | Peer Perform |
2020-04-22 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
2020-04-01 | アップグレード | Goldman | Neutral → Buy |
2020-03-05 | 開始されました | Citigroup | Buy |
2020-02-13 | 開始されました | Goldman | Neutral |
2020-02-06 | 再開されました | BTIG Research | Buy |
2019-12-30 | 繰り返されました | Cowen | Outperform |
2019-12-19 | ダウングレード | Needham | Strong Buy → Buy |
2019-09-05 | 再開されました | JP Morgan | Overweight |
2019-09-03 | 再開されました | Barclays | Overweight |
2019-05-13 | アップグレード | Evercore ISI | In-line → Outperform |
2018-11-28 | 開始されました | UBS | Buy |
2018-10-16 | 開始されました | Barclays | Overweight |
2018-10-02 | 繰り返されました | Morgan Stanley | Overweight |
2018-09-07 | 繰り返されました | Needham | Strong Buy |
2018-09-04 | アップグレード | Jefferies | Hold → Buy |
2018-07-06 | 繰り返されました | Needham | Strong Buy |
2018-06-27 | 開始されました | Bernstein | Outperform |
2018-04-26 | 繰り返されました | Needham | Strong Buy |
すべてを表示
Boston Scientific Corp (BSX) 最新ニュース
Boston Scientific (BSX) Up 3.3% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Boston Scientific (BSX) Price Target Raised by Citigroup | BSX S - GuruFocus
India Catheters Market Set to Witness Significant Growth - openPR.com
Was Jim Cramer Right About Boston Scientific Corporation (BSX)? - Insider Monkey
Endoscopy Devices Global Market Overview 2021-2030 with Forecasts 2024-2030 - GlobeNewswire Inc.
Global Foley Catheters Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~9% by 2032 | DelveInsight - GlobeNewswire Inc.
Boston Scientific Acurate neo2 fails to meet non-inferiority in study - MassDevice
July 3rd Options Now Available For Boston Scientific (BSX) - Nasdaq
Boston Scientific (BSX) Target Price Increased by Citi Analyst | - GuruFocus
Boston Scientific has positive real-world Acurate Prime TAVI data - MassDevice
Here's How Much You'd Have If You Invested $1000 in Boston Scientific a Decade Ago - Yahoo Finance
$1000 Invested In Boston Scientific 15 Years Ago Would Be Worth This Much TodayBoston Scientific (NYSE:BSX) - Benzinga
Boston Scientific’s rating upgraded to A3 by Moody’s Ratings - Investing.com
Market shift: Boston Scientific emerges as Massachusetts' most valuable public company - The Business Journals
Boston Sci Closes Division Sale to Stryker Corp. On Jan. 3, Boston Scientific Corp. completed the - Medical Product Outsourcing
Boston Scientific Adds Seat to Board - Medical Product Outsourcing
Boston Scientific and Other Firms Gain Favorable Ruling in Patent Infringement Case - Medical Product Outsourcing
Boston Scientific Loses Federal Case Over Vaginal Mesh Product - Medical Product Outsourcing
Boston Scientific (NYSE:BSX) Ticks All The Boxes When It Comes To Earnings Growth - Yahoo Finance
Boston Scientific Expands Board with Two New Members - Medical Product Outsourcing
Boston Scientific Posts First-Quarter Profit - Medical Product Outsourcing
Boston Scientific Stents Get FDA Nod for Heart Attack Patients - Medical Product Outsourcing
Forecasting The Future: 9 Analyst Projections For Boston Scientific - Benzinga
Boston Scientific (BSX) Price Target Raised by Morgan Stanley | BSX Stock News - GuruFocus
Colonoscopes Market Report 2025: Valued at $2.5 Billion and Projected to Reach $3.4 Billion by 2030 - GlobeNewswire Inc.
Boston Scientific Launches Next Generation of Cardiac Mapping for the FARAPULSE™ Pulsed Field Ablation System - Quantisnow
Boston Scientific Exec Joins Arsenal Medical’s Board - Medical Product Outsourcing
Ureteral Stents Market Detailed In New Research Report 2025 | - openPR.com
Is it Worth Retaining Boston Scientific Stock in Your Portfolio Now? - Yahoo Finance
Boston Scientific at Bank of America Conference: Strategic Growth Insights - Investing.com
Boston Scientific To Present At Bank Of America's Health Care Conference; Webcast At 11:00 AM ET - Nasdaq
Product liability lawsuits target Medtronic, Boston Scientific spinal cord stim tech - MassDevice
Electroceuticals Market Top PlayersMedtronic Plc (Ireland), - openPR.com
What Makes Boston Scientific Corporation (BSX) A Compelling Name Within The Large-Cap Medical Device Space? - Yahoo Finance
Why Boston Scientific Corporation (BSX) Is Among the Best Medical Device Stocks to Buy Now - Insider Monkey
Erste Group initiates Boston Scientific with Buy, sees growth By Investing.com - Investing.com Canada
Erste Group initiates Boston Scientific with Buy, sees growth - Investing.com
Boston Scientific (BSX) Coverage Reinstated with Buy Rating by A - GuruFocus
Boston Scientific (BSX) Coverage Reinstated with Buy Rating by Analyst | BSX Stock News - GuruFocus
Here is What to Know Beyond Why Boston Scientific Corporation (BSX) is a Trending Stock - Yahoo Finance
Boston Scientific completes SoniVie acquisition - MassDevice
Insider Sell: John Sorenson Sells Shares of Boston Scientific Corp (BSX) - GuruFocus
Boston Scientific Stock Flirts With A Buy Point, Once Again - Investor's Business Daily
Boston Scientific Corporation (BSX) Announces Results of 2025 Annual Meeting of Stockholders - GuruFocus
The Zacks Analyst Blog Highlights GE Healthcare, Johnson & Johnson, Abbott and Boston Scientific - Barchart.com
These 4 Measures Indicate That Boston Scientific (NYSE:BSX) Is Using Debt Safely - Yahoo Finance
Are Wall Street Analysts Predicting Boston Scientific Stock Will Climb or Sink? - Nasdaq
Are Wall Street Analysts Predicting Boston Scientific Stock Will Climb Or Sink? - Barchart.com
Boston Scientific announces results for first quarter 2025 - ADVFN
Boston Scientific Chief Financial Officer (CFO) Dan Brennan to retire; Jon Monson, senior vice president, Investor Relations to succeed Brennan - ADVFN
Boston Scientific, FDA Sued Over 'Unsafe' Spinal Implant - Law360
Boston Scientific Corp (BSX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):